Routine ganglionic plexi ablation during Maze procedure improves hospital and early follow-up results of mitral surgery  by Onorati, Francesco et al.
ET
Evolving Technology Onorati et alRoutine ganglionic plexi ablation during Maze
procedure improves hospital and early follow-up results
of mitral surgery
Francesco Onorati, MD,a Antonio Curcio, MD,b Giuseppe Santarpino, MD,a Daniele Torella, MD,b
Pasquale Mastroroberto, MD,a Luigi Tucci, MD,c Ciro Indolfi, MD, FESC,b and Attilio Renzulli, MD, PhD, FECTSa
Objective: Ganglionic plexi are claimed to be potentially responsible for atrial fibril-
lation. We evaluated whether ganglionic plexi isolation improves the results of the
Maze procedure during mitral valve surgery.
Methods: A total of 75 patients with atrial fibrillation underwent radiofrequency ab-
lation during mitral valve surgery without (group A) or with (group B) ganglionic
plexi ablation with bipolar radiofrequency plus fat pad resection along the Waterston
groove, left pulmonary veins, and Marshall’s ligament. Ganglionic plexi were intra-
operatively mapped, and fat pad specimens were sectioned and analyzed. Hospital and
follow-up results were recorded. Amiodarone was discontinued at the sixth month.
Results: Active ganglionic plexi were mainly located in the upper parts of fat pads.
Active specimens demonstrated more ganglionic plexi than inactive specimens (P
# .015 at different levels) but did not correlate with atrial fibrillation recurrence
(P 5 not significant). Atrial fibrillation was higher in group A at aortic declamping
(P 5 .03) and discharge (P 5 .03). Early events were comparable (P 5 .565). At
16.7 6 0.95 (standard error) months, the cumulative freedom from atrial fibrillation,
atrial flutter, and atrial tachycardia with antiarrhythmic therapy was 63.2% 6 7.3%
and proved higher in group B (83.9% 6 7.9% vs group A 52.8% 6 8.7%; P 5
.035). However, after the sixth month, at 12.86 0.80 months, freedom from atrial fi-
brillation, atrial flutter, and atrial tachycardia without antiarrhythmic therapy was
72.5% 6 7.7% and proved higher in group B (92.9% 6 6.9% vs 62.5% 6 9.4%; P
5 .023). A higher proportion of patients in group B showed normalized E/A ratio
(61.3% vs group A 36.4%; P5 .029). No differences were detected in follow-up free-
dom from congestive heart failure (group A: 83.4% 6 7.0% vs group B: 93.5% 6
4.4%; P 5 .978) and hospital readmission (group A: 84.2% 6 5.9% vs group B:
92.6% 6 5.1%; P 5 .376).
Conclusion: Ganglionic plexi isolation can improve hospital and follow-up results
during mitral valve surgery and possibly ameliorate echocardiographic recovery of
atrial function during follow-up.
S
ince Cox proved that atrial fibrillation (AF) could be treated by means of sur-
gery,1 a growing number of modified ‘‘mini-Maze’’ procedures have been pro-
posed to overcome the problems of complexity and prolonged operating time
of the Cox–Maze III technique.2,3 Along with the demonstration by Haissaguerre and
colleagues4 of the key role of ectopic triggers localized in the pulmonary veins, recent
literature data also have shown a role of epicardial ganglionic plexi (GP), which are
primarily found in the epicardial fat tissue of the upper half part of the heart, in deter-
mining or inducing AF.5,6 Accordingly, some articles from electrophysiologic groups
have addressed the safety, feasibility, and efficacy of sinus rhythm (SR) recovery after
GP catheter ablation in paroxysmal AF.7,8 Furthermore, it was recently confirmed
with electrophysiologic mapping that active GP are clustered around the interatrial
groove and the ligament of Marshall, and that cardiac response to GP stimulation
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ETAbbreviations and Acronyms
AF 5 atrial fibrillation
AFL 5 atrial flutter
AT 5 atrial tachycardia
CHF 5 congestive heart failure
GP 5 ganglionic plexi
NYHA 5 New York Heart Association
RF 5 radiofrequency
SR 5 sinus rhythm
can be eliminated with surgical bipolar radiofrequency (RF)
isolation.9 On the other hand, Alex and Guvendik11 failed to
demonstrate any role of cardiac denervation on AF recur-
rences after surgery. Different techniques aimed at reducing
postoperative autonomic imbalance (eg, thoracic epidural an-
esthesia) also failed to reduce postoperative AF.11 Therefore,
despite the postulated role for surgical GP isolation, there is
no general agreement on the efficacy of strategies targeting
the autonomic nervous system on postoperative AF.7-10 Al-
though surgical AF ablation with modified ‘‘mini-Maze’’
procedures is now considered curative for the majority of pa-
tients referred to surgery,2 it still carries the risk for AF recur-
rence, estimated to range from 10% to 40% in the different
series, during the short- and mid-term follow-ups.11,12 We
hypothesized that GP isolation with bipolar RF ablation
may increase freedom fromAF in patients undergoing persis-
tent/long-standing persistent AF ablation during concomitant
mitral valve surgery. The present study analyzes the hospital
and short-term follow-up outcomes of patients undergoing 2
different surgical strategies (mini-Maze vs mini-Maze 1 GP
isolation) used in the last 2.5 years to treat AF in patients
undergoing mitral valve surgery.
Materials and Methods
From January of 2005 to October of 2007, 75 patients with persis-
tent or longstanding persistent AF who required mitral valve surgery
were enrolled in this prospective study after the approval of the in-
stitution’s (Cardiac Surgery Unit Magna Graecia University) ethical
committee/institutional review board and informed consent had
been obtained. The study design was set to enroll patients undergo-
ing the mini-Maze during mitral valve surgery in the first period
(January of 2005 to September of 2006) and to compare hospital
outcome and short-term follow-up with that of patients undergoing
the combined mini-Maze 1 GP isolation and mitral valve surgery
during the second period of the study (September of 2006 to October
of 2007). AF was defined as persistent or longstanding persistent
according to the Heart Rhythm Society, European Heart Rhythm
Association, and European Cardiac Arrhythmia Society.14 The
demographics are reported in Table 1.
Surgery
Cardiopulmonary bypass was standardized.13 Cardiac arrest was
achieved with intermittent antegrade plus retrograde blood cardio-The Journal of Thorplegia. Mitral valve surgery was performed through a longitudinal
atriotomy. Mitral valve replacement was always achieved by im-
planting prostheses in the intra-annular position.When tricuspid dis-
ease was encountered, longitudinal intercaval right atriotomy was
used as the surgical access. Intraoperative data and concomitant pro-
cedures are also shown in Table 1.
With regard to arrhythmia surgery, 2 different surgical strategies
were adopted: A total of 44 patients underwent the isolated ‘‘left 1
right mini-Maze’’ procedure (group A) as previously reported,12
preferentially during the first phase of the study, and the remaining
31 patients (group B) underwent the ‘‘left 1 right mini-Maze’’
TABLE 1. Demographic and intraoperative data
Group A
(44 patients)
Group B
(31 patients) P
Age (y) 64.6 6 10.3 64.2 6 9.8 .849
Age . 65 y 21 (47.7%) 21 (67.7%) .068
Sex (male) 33 (75.0%) 23 (74.2%) .572
Diabetes mellitus 14 (31.8%) 11 (35.5%) .465
Hypertension 33 (75.0%) 22 (71.0%) .448
Dyslipidemia 24 (54.5%) 13 (41.9%) .200
COPD 19 (43.2%) 10 (32.3%) .238
.90 kg (weight) 12 (27.3%) 6 (19.4%) .306
Mitral disease 44 (100%) 31 (100%) -
Aortic disease 22 (50.0%) 11 (35.5%) .156
Tricuspid disease 16 (36.4%) 14 (45.2%) .299
Coronary heart disease 5 (11.4%) 4 (12.9%) .556
Longstanding persistent AF 38 (86.4%) 27 (87.1%) .605
Persistent AF 6 (13.6%) 4 (12.9%) .605
AF duration (mo) 29.1 6 10.7 27.5 6 11.4 .548
Preoperative NYHA 3.68 6 0.47 3.58 6 0.62 .425
Preoperative heart failure state 14 (31.8%) 11 (35.5%) .465
Previous pharmacologic
cardioversion
44 (100%) 31 (100%) -
Previous electric cardioversion 17 (38.6%) 8 (25.8%) .181
Preoperative LVEF 45.6 6 10.4 44.8 6 9.6 .738
Preoperative LVEF , 45% 26 (59.1%) 17 (54.8%) .448
Preoperative transverse LAD 53.7 6 6.7 53.5 6 7.6 .906
Preoperative longitudinal LAD 57.3 6 9.9 59.2 6 12.6 .553
Mitral valve replacement
(mechanical)
7 (15.9%) 8 (25.8%) .222
Mitral valve replacement
(biologic)
4 (9.1%) - .112
Mitral valve plasty 33 (75.0%) 23 (74.2%) .572
Aortic valve replacement
(mechanical)
7 (15.9%) 4 (12.9%) .493
Aortic valve replacement
(biologic)
5 (11.4%) 2 (6.5%) .384
Aortic valve plasty 3 (6.8%) 5 (16.1%) .182
Tricuspid valve plasty 16 (36.4%) 14 (45.2%) .299
CABG 5 (11.4%) 4 (12.9%) .556
Crossclamp time 60.2 6 15.1 59.1 6 11.3 .730
Cardiopulmonary bypass time 83.7 6 12.5 81.2 6 14.1 .407
AF,Atrial fibrillation; COPD, chronic obstructive pulmonary disease; LAD, left
atrial diameter; LVEF, left ventricular ejection fraction; NYHA, New York
Heart Association; CABG, coronary artery bypass grafting.acic and Cardiovascular Surgery c Volume 136, Number 2 409
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ETprocedure plus GP isolation, preferentially during the second phase
of the study. Briefly, left-sided lesions were in the pulmonary veins
and left atrial appendage bipolar RF isolation, with the bipolar clamp
(Medtronic, Minneapolis, Minn) and Cardioblate surgical ablation
generator (Medtronic) as the power source. The left isthmus lesion
was always performed with a unipolar RF pen (Cardioblate surgical
pen; Medtronic). The left lesion set was completed by bipolar RF le-
sion connecting the left upper pulmonary vein to the left atrial ap-
pendage. Right-sided ablation lines were created as previously
reported, always using a bipolar clamp.12 Briefly, a purse-string su-
ture stitched in front of the coronary sinus was used to insert the bi-
polar clamp, which was first directed between the inferior vena cava
and the coronary sinus, and then rotated toward the atrioventricular
groove, between the coronary sinus and the tricuspid valve, to ablate
the cavo-tricuspid isthmus. The clamp was subsequently rotated up-
ward to create a transmural ablation line, connecting the purse string
to the right appendage. Finally, an additional purse-string suture was
stitched on the tip of the right atrial appendage (for venous drain-
age), through which the bipolar clamp was introduced to first allow
an ablative line connecting the superior vena cava to the inferior
vena cava and then to ablate the terminal crest. Off-pump ablation
of the right appendage completed the procedure.12 Because of the
risk of incomplete right septal isthmus ablation, patients with a large
right atrium ($7.0 cm) undergoing tricuspid valvuloplasty also un-
derwent further monopolar RF septal isthmus ablation. Left and
right appendages were always excluded by external ligation or inter-
nal stitching.12
Ganglionic Plexi Isolation
In patients undergoing GP isolation, intraoperative epicardial elec-
trophysiologic mapping was performed at the time of operation,
starting from the right-sided pulmonary veins, moving from the
area of the superior right pulmonary vein to that of the inferior right
pulmonary vein, and then moving in the same manner to the left-
sided pulmonary veins. Intraoperative epicardial electrophysiologic
mapping was performed using a standard 6F catheter (FIAB SpA,
Florence, Italy). The catheter was connected to an external pulse
generator (St Jude Medical Inc, St Paul, Minn) to deliver high-
frequency stimulation (at a rate of 800/min, amplitude of 12 to 16
mA, with a pulse duration of 9.9 ms) to the above-mentioned areas.
The electrocardiogram was monitored, and stimulation that resulted
in a doubling of the R-R interval indicated an active GP.9 A bipolar
RF lesion encompassing the right-sided interatrial fat pad of Water-
ston’s groove, as suggested by Mehall and coworkers,9 was then
made. This lesion was created with 1 jaw of the bipolar clamp pos-
terior to the right-sided pulmonary veins and the other jaw on the
right atrium, medial to the interatrial fat pad, to encompass part of
the left atrium, right atrium, and interatrial septum. Another bipolar
RF clamping was made jawing the ligament of Marshall.9 GP areas
that had preablation activity were then restimulated to confirm the
isolation. Both lesions involving GP locations were made off
pump and at least twice to achieve isolation. Extended fat pat resec-
tion along Waterston’s groove, the ligament of Marshall, and the
left-sided pulmonary veins was then executed to demonstrate GP
with pathologic analysis on the specimens. Each right- and left-sided
fat pad specimen was divided into 3 portions (superior, middle, and
inferior), and active ganglia were localized in each specimen. To dif-
ferentiate ganglia from nerves, specimens were stained with hema-
toxylin/eosin and antibodies to S100 protein and neurofilaments.410 The Journal of Thoracic and Cardiovascular Surgery c AugHowever, except for the surgical AF ablation technique, preopera-
tive, intraoperative, and postoperative management techniques
were standard during the entire study period.
Postoperative Care
Inotropic support was defined as low dose when enoximone was ad-
ministered at a dosage of 5 mg/kg/min or less, medium dose when
enoximone was administered at a dosage of 6 to 10 mg/kg/min or do-
butamine was added from 5 to 10 mg/kg/min, and high dose when
enoximone or dobutamine was administered at a dosage of 10 mg/
kg/min or epinephrine at any dose was added.
An intravenous amiodarone bolus (150 mg), followed by contin-
uous intravenous infusion at 1 mg/kg/h for 12 hours and then 0.5
mg/kg/h until patients tolerated oral intake, was routinely adminis-
tered intraoperatively. Patients then underwent oral amiodarone
(200 mg twice per day for 1 week, then 200 mg daily) until the sixth
postoperative month. Patients with postoperative persistence of AF,
as well as those with new-onset AF, did not undergo electrical
cardioversion but were treated with intravenously and orally adminis-
tered amiodarone. The international normalized ratio was maintained
between 2.5 and 3.5 for the first 6 months in all patients and lifelong
in patients receiving mechanical valves or with AF persistence.
Assessment of Cardiac Rhythm and Follow-up
Twelve-lead electrocardiographic recordings were performed pre-
operatively, on admission to the intensive therapy unit, and daily
thereafter until hospital discharge or whenever necessary. All pa-
tients underwent continuous electrocardiographic monitoring for
the first 72 hours postoperatively. The incidence of arrhythmias,
both atrial and ventricular, was recorded during hospitalization
and follow-up. The mean follow-up time was 16.76 0.95 (standard
error) months (confidence limit 14.9–18.6 months), and no patient
was lost during follow-up (100% complete). An initial post-ablation
blanking period of 3 months was considered according to the Heart
Rhythm Society, European Heart Rhythm Association, and Euro-
pean Cardiac Arrhythmia Society: The reported recurrences during
the post-ablation blanking period were defined as ‘‘early events.’’11
Follow-up data were collected by routine examination in our outpa-
tient clinic (7 days, 14 days, 1 month, 3 months, 6 months, and 1
year after surgery, and then once per year or whenever requested
by the patient). Phone contacts with patients and cardiologists
were made whenever necessary. One month after surgery, patients
underwent 24-hour Holter electrocardiography, which was repeated
at least once during the first 6 months of follow-up. According to the
Heart Rhythm Society, European Heart Rhythm Association, and
European Cardiac Arrhythmia Society, 6- and 12-month follow-
ups were recorded. Follow-up was closed on November 30, 2007.
End Points
The primary efficacy end point was freedom from AF, atrial flutter
(AFL), and atrial tachycardia (AT) of at least 30 seconds duration in
the absence of antiarrhythmic drug therapy 3 months after stopping
amiodarone.11 The prevalence of AF at 6 and 12 months postoper-
atively were also recorded. Secondary end points were freedom
from AF, AFL, and AT in the presence of antiarrhythmic therapy,
prevalence of ‘‘early events’’ during the post-ablation blanking
period of 3 months, in-hospital electrophysiologic results, and
freedom from episodes of congestive heart failure (CHF) and hospi-
tal readmission. CHF was defined as any episode of cardiacust 2008
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apy or hospitalization; hospital readmission was defined as any hos-
pital admission for any cardiac cause and requiring more than
a 6-hour stay. As a surrogate outcome of cardiac compensation,
the need and dose of furosemide were registered preoperatively, at
hospital discharge, and at the end of follow-up.
Echocardiography
The echocardiographic examinations were performed preopera-
tively, postoperatively, and at 6 months follow-up using a VIVID
7 Pro ultrasound machine (GE Technologies, Milwaukee, Wis).
Atrial and ventricular remodeling (longitudinal and transverse atrial
diameters, diastolic ventricular diameter), systolic pulmonary arte-
rial pressure, indexed left ventricular mass, and E/A ratio recovery
were investigated.
Statistical Analysis
Continuous variables are expressed as mean 6 standard devia-
tion, and categoric data are expressed as proportions. Compari-
sons of continuous variables were made with the Student
unpaired t test, and categoric variables were compared with the
chi-square test or Fisher exact test. Comparison between and
within groups was made using 2-way analysis of variance for re-
peated measures.
Freedom from AF, AFL, AT, CHF, and hospital readmission
was determined by means of the Kaplan–Meier life-table analysis.
Log-rank test was performed to ascertain differences during fol-
low-up between patients undergoing the isolated left 1 right mini-
Maze procedure and those undergoing combined GP isolation. All
statistical analyses were performed with the Statistical Package for
the Social Sciences 13.0 (SPSS Inc, Chicago, Ill).
Results
Hospital Mortality, Morbidity, and Drug-related
Complications
There were no hospital deaths during hospitalization or abla-
tion device-related complications. Hospital morbidity is
reported in Table 2. No differences were registered in perio-
perative inotropic support (Table 2).
TABLE 2. Hospital morbidity and perioperative inotropic
support
Group A
(44 patients)
Group B
(31 patients) P
Morbidity 7/44 (15.9%) 6/31 (19.4%) .464
LOS 2/44 (4.5%) 2/31 (6.5%) .551
ARF 3/44 (6.8%) 2/31 (6.5%) .664
Pneumonia 2/44 (4.5%) 2/31 (6.5%) .551
LD inotropic support 24/44 (54.5%) 18/31 (58.1%) .474
MD inotropic support 16/44 (36.4%) 11/31 (35.5%) .567
HD inotropic support 4/44 (9.1%) 2/31 (6.5%) .516
ITU stay (h) 51.6 6 9.6 50.2 6 6.5 .481
Hospital stay (d) 9.0 6 12.5 7.3 6 0.8 .481
LOS, Low output syndrome; ARF, acute renal failure; LD, low dose; MD,
medium dose; HD, high dose; ITU, intensive therapy unit.The Journal of ThoWhen chronic amiodarone therapy was considered, only 1
patient in group A (2.3%; P 5 .587) experienced optic neu-
ropathy at 4 months after surgery, with partial improvement
after drug discontinuation. However, all other patients con-
tinued amiodarone until the sixth month. Finally, no warfa-
rin-related complications were registered during the study.
Pathologic Analysis
The details of the site and number of GPs detected at pathol-
ogy are shown in Table 3. As evidenced, GPs are generally
clustered in a higher number on the upper right and left fat
pad specimens. No GP can be demonstrated in 1 superior,
6 middle, and 12 inferior right fat pad specimens, and in 11
superior, 4 middle, and 7 inferior left fat pad specimens (Ta-
ble 3). Obviously, none of these specimens were active at in-
traoperative electrophysiologic analysis. A mean of 3.09 6
1.13 GP (range 0–5) in the superior, 1.70 6 1.04 GP (range
TABLE 3. Number of ganglionic plexi found at pathologic
analysis in each patient
Superior
right FPS
Middle
right FPS
Inferior
right FPS
Superior
left FPS
Middle
left FPS
Inferior
left FPS
Patient 1 4.00 3.00 3.00 3.00 3.00 3.00
Patient 2 3.00 2.00 2.00 3.00 3.00 2.00
Patient 3 3.00 2.00 3.00 2.00 3.00 2.00
Patient 4 4.00 2.00 2.00 2.00 2.00 2.00
Patient 5 4.00 3.00 2.00 4.00 2.00 1.00
Patient 6 4.00 2.00 3.00 3.00 2.00 1.00
Patient 7 3.00 2.00 2.00 2.00 2.00 1.00
Patient 8 3.00 2.00 1.00 2.00 2.00 1.00
Patient 9 3.00 3.00 1.00 3.00 1.00 1.00
Patient 10 3.00 2.00 0.00 3.00 1.00 1.00
Patient 11 3.00 2.00 2.00 1.00 1.00 1.00
Patient 12 3.00 2.00 1.00 1.00 1.00 1.00
Patient 13 4.00 1.00 2.00 0.00 1.00 0.00
Patient 14 3.00 3.00 2.00 0.00 1.00 2.00
Patient 15 3.00 3.00 2.00 0.00 1.00 1.00
Patient 16 3.00 1.00 0.00 0.00 1.00 1.00
Patient 17 3.00 2.00 0.00 0.00 1.00 1.00
Patient 18 4.00 2.00 0.00 0.00 1.00 1.00
Patient 19 4.00 0.00 1.00 0.00 1.00 0.00
Patient 20 5.00 2.00 1.00 1.00 1.00 1.00
Patient 21 4.00 3.00 2.00 1.00 1.00 1.00
Patient 22 4.00 3.00 1.00 1.00 1.00 1.00
Patient 23 5.00 2.00 1.00 1.00 1.00 1.00
Patient 24 3.00 2.00 0.00 1.00 1.00 1.00
Patient 25 3.00 1.00 0.00 1.00 1.00 1.00
Patient 26 3.00 1.00 0.00 0.00 1.00 1.00
Patient 27 1.00 0.00 0.00 2.00 1.00 0.00
Patient 28 1.00 0.00 0.00 0.00 0.00 0.00
Patient 29 0.00 0.00 0.00 1.00 0.00 0.00
Patient 30 1.00 0.00 0.00 0.00 0.00 0.00
Patient 31 2.00 0.00 0.00 0.00 0.00 0.00
FPS, Fat pad specimen.racic and Cardiovascular Surgery c Volume 136, Number 2 411
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ET0–3) in the middle, and 1.09 6 1.04 GP (range 0–3) in the
inferior right fat pad specimens were demonstrated. Simi-
larly, a mean of 1.22 6 1.20 GP (range 0–4), 1.22 6 0.80
GP (range 0–3), and 0.96 6 0.70 GP (range 0–3) were de-
tected in the superior, middle, and inferior left fat pad speci-
mens, respectively.
On the other hand, the prevalence of active sites along the
fat pad specimens, as demonstrated by intraoperative electro-
physiologic mapping, is shown in Figure 1. Inactive zones
did not undergo further electrophysiologic stimulation with
different frequencies, pulse durations, or amplitudes. Active
sites were found bilaterally in 16 patients, unilaterally right
sided in 8 patients, and left sided in 7 patients. When active
fat pad specimens were compared with inactive fat pad spec-
imens, a significantly higher number of GP were detected by
the pathologist in active specimens (superior right: 3.54 6
0.65 vs 1.576 1.13 in inactive specimens, P5 .003; middle
right: 2.16 6 0.61 vs 1.07 6 1.18, P 5 .008; inferior right:
2.42 6 0.53 vs 0.70 6 0.80, P 5 .0001; superior left: 2.70
6 0.67 vs 0.52 6 0.60, P 5 .0001; middle left: 2.37 6
0.51 vs 0.82 6 0.38, P 5 .0001; inferior left: 2.0 6 0.70
vs 0.76 6 0.51, P 5 .015). All patients in whom AF recur-
rences developed during follow-up demonstrated at least 1
active fat pad zone. However, no differences were found in
the number and site of GP in patients demonstrating AF re-
currences during follow-up compared with patients maintain-
ing SR (superior right: AF 3.00 6 1.41 vs SR 3.11 6 1.12,
P 5 .859; middle right: 1.25 6 1.25 vs 1.78 6 1.01, P 5.352; inferior right: 1.25 6 1.50 vs 1.07 6 0.99, P 5 .759;
superior left: 1.00 6 1.41 vs 1.25 6 1.19, P 5 .695; middle
left: 1.256 1.26 vs 1.226 0.75, P5 .950; inferior left: 1.00
6 1.41 vs 0.96 6 0.58, P 5 .962).
Cardiac Rhythm
On aortic declamping, 51 patients (68.0%) recovered SR, 14
patients (18.7%) were in junctional rhythm, and 10 patients
(13.3%) displayed persistence of AF. Only 1 case of AF per-
sistence was registered at aortic declamping in group B, and 9
cases were registered in group A (20.5% vs group B 3.2%;
P 5 .030). No differences were recorded between the 2
groups in SR (30/44 [68.2%] vs group B: 21/31 [67.7%]; P
5 .581) and junctional rhythm requiring temporary pace-
maker stimulation (5/44 [11.4%] vs group B: 9/31 [29.0%];
P 5 .052). Of these, only 1 patient (1.3% of the global pop-
ulation) in group A (2.3% vs group B 0%; P5 .587) required
definitive pacemaker implantation.
All patients were treated with amiodarone postopera-
tively; thus, 64 patients (85.3%) recovered and were dis-
charged in SR, and 10 patients (13.3%) were discharged in
AF. With regard to AFL, postoperative transient AFL devel-
oped during hospitalization in 11 patients (14.7%), without
differences between the 2 groups (group A: 7/44 [15.9%]
vs group B: 4/31 [12.9%]; P5 .493). On discharge, a signif-
icantly higher prevalence of AF was noted in group A (9/44
[20.5%] vs group B: 1/31 [3.2%]; P 5 .030), together with
a lower prevalence of SR (group A: 34/44 [77.3%] vs groupFigure 1. A, Electrophysiologic mapping of active GP. GP demonstration on fat pad specimen stained with hematox-
ylin/eosin (B) and antibodies to neurofilaments (C). LA, Left atrium; RA, right atrium; PA, pulmonary artery; LV, left
ventricle.
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‘‘early events’’ during the post-ablation blanking period of 3
months between the 2 groups (group A: 5/44 [11.4%] vs
group B: 3/31 [9.7%]; P 5 .565). After antiarrhythmic ther-
apy discontinuation, no differences in the prevalence of AF,
AFL, and AT were registered at 6 months (group A: 4/36–
11.1% vs group B: 1/29–3.4%; P5 .252), but a significantly
lower AF, AFL, and AT prevalence was recorded in group B
at 12 months (1/11 [9.1%] vs group A:14/33 [42.4%]; P 5
.044). At a mean of 11.7 6 5.9 months follow-up (range
1–22 months), 57 patients (76.0%) were in SR. Actuarial
freedom from AF, AFL, and AT recurrence with antiarrhyth-
mic therapy after 16.7 6 0.95 (standard error) months was
63.2% 6 7.3% (Figure 2, A) and proved higher in group B
(Figure 2, B). However, after the sixth month, 12.8 6 0.80
(standard error) months, freedom from AF, AFL, and AT
without antiarrhythmic therapy was 72.5%6 7.7% (Figure 2,
C) higher in group B (Figure 2, D).When AF-surgery related complications were considered,
no cases of cardiac tamponade, pulmonary vein stenosis,
esophageal injury, phrenic/vagal nerve injury, coronary
occlusions, or thromboembolism were registered.
Hemodynamic Status, Congestive Heart Failure, and
Hospital Readmission
NewYork Heart Association (NYHA) class improved signif-
icantly after surgery within the 2 groups (group A preopera-
tive: 3.68 6 0.47 vs discharge: 1.45 6 0.58, P 5 .0001;
group B preoperative: 3.58 6 0.62 vs discharge: 1.35 6
0.48, P 5 .0001) and further ameliorated during follow-up
(group A follow-up NYHA: 1.16 6 0.48, P 5 .0001; group
B follow-up NYHA: 1.19 6 0.40, P 5 .0007; statistical sig-
nificance between groups: P5 .517). On the other hand, pa-
tients with AF displayed less improvement in NYHA class
than those with SR at discharge and during follow-up (preop-
erative NYHA of patients with AF: 3.706 0.46 vs NYHA onETFigure 2. Cumulative freedom from AF, AFL, and AT with antiarrhythmic therapy (A), freedom from AF, AFL, and AT
with antiarrhythmic therapy between the 2 groups (B), cumulative freedom from AF, AFL, and ATwithout antiarrhyth-
mic therapy (C), and freedom from AF, AFL, and ATwithout antiarrhythmic therapy between the 2 groups (D). AF, Atrial
fibrillation; AFL, atrial flutter; AT, atrial tachycardia.
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ETdischarge: 1.76 6 0.66 vs follow-up NYHA: 1.52 6 0.62,
statistical probability within subjects P 5 .040; preoperative
NYHA of patients with SR: 3.62 6 0.55 vs NYHA on dis-
charge: 1.316 0.46 vs follow-up NYHA: 1.066 031, statis-
tical probability within subjects P 5 .0001; statistical
probability between groups P 5 .001). When furosemide
therapy was considered, of 42 patients in group A (95.5%)
and 31 patients in group B (100%; P5 .341), who were tak-
ing diuretics on hospital admission, 41 patients in group A
(93.2%) and 29 patients in group B (93.5%; P 5 .664)
were discharged with furosemide. Of these, 22 patients in
group A (50.0%) and 17 patients in group B (54.8%; P 5
.430) continued to take diuretics at the end of follow-up.
However, a significantly higher diuretic dose was necessary
in group A (preoperative: 51.7 6 24.8 mg/d vs discharge:
55.16 20.1 mg/d vs follow-up: 19.66 16.6; P5 .070 within
group) compared with group B (preoperative: 70.2 6 26.1
mg/d vs discharge: 32.2 6 16.6 mg/d vs follow-up: 13.7 6
13.8; P 5 .0001 within group; statistical significance
between groups: P5 .0001). Moreover, patients maintaining
SR at discharge and during follow-up needed less diuretics
than patients experiencing AF recurrence, either in group A
(SR at discharge: 36.3 6 22.2 mg/d vs AF at discharge:
100.0 6 51.1; P 5 .0001; SR at follow-up: 9.6 6 11.9 mg/
d vs AF at follow-up: 43.26 34.8; P5 .0001; statistical sig-
nificance between groups: P5 .0001) or group B (SR at dis-
charge: 28.7 6 13.3 mg/d vs AF at discharge: 56.2 6 12.5;
P 5 .001; SR at follow-up: 11.1 6 12.2 mg/d vs AF at fol-
low-up: 31.2 6 12.5; P 5 .005; statistical significance be-
tween groups: P 5 .003).
Seven patients in group A had episodes of CHF during fol-
low-up, giving a global actuarial freedom from CHF of
84.0% 6 6.4% (Figure 3, A). However, no differences were
recorded between the 2 groups in follow-up freedom from
CHF (Figure 3, B). On the other hand, 8 patients were read-
mitted to hospital during follow-up, meaning that cumulative
actuarial freedom from hospital readmission was 87.3% 6
4.3% (Figure 3, C). Again, no differences were detected
Figure 3. Cumulative freedom from CHF (A), freedom from CHF between the 2 groups (B), cumulative freedom from
hospital readmission (C), and freedom from hospital readmission between the 2 groups (D). CHF, Congestive heart
failure.
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readmission (Figure 3, D).
Echocardiographic Results
Echocardiography documented a normalized E/A in 35 pa-
tients (46.7% of global population, 61.4% of patients with
SR) at the end of follow-up. Patients undergoing GP isolation
demonstrated a higher prevalence of normalized E/A (group
B: 19/31 [61.3%] vs group A: 16/44 [36.4%], P 5 .029; 19/
27 patients with SR [70.4%] vs 16/30 patients with SR
[53.3%], P 5 .148).
When groups A and B were compared, no differences in
follow-up echocardiographic parameters were detected;
both groups showed significant reverse remodeling of longi-
tudinal and transverse atrial diameters, recovery of systolic
pulmonary arterial pressure and indexed left ventricular
mass, and follow-up reverse remodeling of diastolic left ven-
tricular diameter (Table 4).
However, patients who recovered SR displayed signifi-
cant reverse remodeling of left atrial longitudinal and trans-
verse diameters on follow-up echocardiography (Table 4).
Such reverse remodeling was not detected in patients in
whom AF persisted (Table 4). Only patients in SR showed
significant reverse remodeling of left ventricular diastolic
diameter during follow-up, as well as a significant improve-
TABLE 4. Echocardiographic results stratified by cardiac
rhythm and surgical treatment
Discharge Follow-up P a P b
Longitudinal LAD SR 58.4 6 7.0 51.7 6 7.4 .0001 .0001
AF 61.5 6 9.4 60.8 6 9.5 .120
Transverse LAD SR 53.5 6 7.7 47.9 6 8.1 .001 .001
AF 54.4 6 7.5 54.0 6 8.2 .181
PAPs SR 33.2 6 2.5 27.4 6 3.2 .008 .005
AF 32.7 6 3.8 31.4 6 3.2 .521
LVMi SR 146.9 6 31.3 130.1 6 29.3 .0001 .08
AF 135.8 6 26.2 125.4 6 25.6 .001
LVDd SR 5.6 6 1.3 5.2 6 1.2 .0001 .001
AF 5.5 6 1.0 5.4 6 1.2 .171
Longitudinal LAD Group A 53.4 6 11.4 51.0 6 9.2 .0001 .465
Group B 54.9 6 10.8 52.9 6 8.8 .0001
Transverse LAD Group A 52.5 6 9.4 51.3 6 7.7 .004 .543
Group B 53.8 6 9.9 51.0 6 8.0 .009
PAPs Group A 32.6 6 8.4 28.6 6 9.9 .015 .426
Group B 33.4 6 9.2 30.4 6 10.4 .034
LVMi Group A 144.6 6 31.2 123.9 6 28.1 .0001 .454
Group B 142.5 6 29.1 125.8 6 27.4 .0001
LVDd Group A 5.4 6 1.0 5.0 6 1.4 .0001 .377
Group B 5.5 6 1.3 5.2 6 1.0 .0001
LAD, Left atrial diameter; PAPs, systolic pulmonary arterial pressure; LVMi,
indexed left ventricular mass; LVDd, diastolic left ventricular diameter. aStat-
istical significance between discharge and follow-up echocardiography
(within groups). bStatistical significance between patients with SR and pa-
tients with AF (first part) and between group A and B (second part) (between
groups).The Journal of Thoment in systolic pulmonary arterial pressure and indexed left
ventricular mass (Table 4). In contrast, patients with AF only
showed a significant improvement in follow-up indexed left
ventricular mass (Table 4).
Discussion
Although it has long been ascertained that AF is frequently
associated in patients with underlying heart disease, inas-
much as it is estimated to be present in 50% of patients
with mitral valve disease, routine ablation of AF in these pa-
tients is a recent phenomenon.2 The Cox maze III operation is
considered the gold standard for surgical treatment of AF,
and other approaches to AF ablation should be measured
against it.1-3 In this surgical procedure, multiple left and right
atrial incisions are placed to interrupt the multiple reentrant
circuits of AF.1 However, the Cox–Maze procedure is a tech-
nically demanding operation with a prolonged operative
time, so that a number of modified ‘‘mini-Maze’’ procedures
with alternative energy sources, other than the cut-and-sew
technique, have been proposed to overcome such matters.2,11
However, if the Cox–Maze technique allows an SR restora-
tion rate of 70% to 95% in the different experiences,2,14,15
the modified so-called mini-Maze procedures have a similar
success rate ranging from 65% to 90%, regardless of the ab-
lative pattern, patient populations, and energy sources.2,16-18
All of these data imply that AF recurrences developed dur-
ing the follow-up in approximately 25% of patients undergo-
ing surgical AF ablation, limiting the primary surgical
success rate. Therefore, despite the fact that Haissaguerre4
demonstrated the importance of ectopic triggers of the pul-
monary veins, different mechanisms can be involved in AF
initiation and recurrence. In the last few years, different stud-
ies have demonstrated a significant role of parasympathetic
autonomic tone in determining AF.5-9,19 Active GP are usu-
ally located in epicardial fat pads along the right-sided intera-
trial groove and along the ligament of Marshall on the left.9
Therefore, their location is often outside the areas tradition-
ally isolated when pulmonary vein isolation alone is per-
formed.9 In particular, it has been demonstrated that GP
play a synergistic role with ectopic vein foci, thus decreasing
the threshold of inducibility for AF.6 GP activation resulted
in a progressive decrease in atrial refractoriness, which re-
mains active even after extracardiac denervation.20 Accord-
ingly, the destruction of GP rendered 96% of patients
noninducible to AF.21 Chiou and Zipes8 obtained selective
vagal denervation of the atria, sinus, and AV nodes, with pre-
served ventricular innervation, with RF ablation of the atrial
fat pad in a dog model. Moreover, Pappone and colleagues22
suggested that patients undergoing AF catheter-based RF ab-
lation with ‘‘vagal’’ response, who demonstrated higher free-
dom from AF during follow-up, had GP destruction with loss
of the GP function during the interventional procedure. Chen
and coworkers23 demonstrated that a disturbed atrial electro-
physiology mediated by higher vagal reflexes could play anracic and Cardiovascular Surgery c Volume 136, Number 2 415
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tricular tachycardias. Finally, Mehall and colleagues9 re-
cently reported that autonomic GP are clustered around the
interatrial groove and the ligament of Marshall, and that car-
diac response to GP stimulation can be eliminated with sur-
gical bipolar RF isolation, suggesting the potential for an
increased freedom from AF with the addition of GP isolation
to bilateral pulmonary vein isolation.9 However, there is no
general agreement on the efficacy on postoperative AF of
strategies targeted on autonomic nervous system: Alex and
Guvendik10 demonstrated that ventral cardiac denervation
was not effective in reducing AF recurrences, whereas Jideus
and colleagues11 showed thoracic epidural anesthesia to have
no effects on postoperative AF. However, the resulting dom-
inating vagotonic status induced by epidural anesthesia, re-
ported by Jideus and colleagues, can explain the results of
their study.We reported our experience with the combination
of GP isolation to traditional RF mini-Maze procedure, and,
as expected, we found a higher, but not significant, freedom
from AF in those patients who underwent combined mini-
Maze plus GP isolation.
It is well known that the topography of cardiac ganglia in
the adult human heart is not common basic or clinical knowl-
edge, due in part to limited or inconsistent reports.24 More-
over, contradictory results are reported in the literature:
Singh and colleagues24 showed 2 large populations of cardiac
ganglia, the first lateral to the right pulmonary veins and in-
ferior to the superior vena cava, near the sinoatrial node,
and the second at the interatrial groove and coronary sulcus
junction, near the AV node, but only small populations lateral
to the left pulmonary veins.24 On the other hand, Leonhardt25
reported similar cardiac ganglia densities near the sinoatrial
node and on the superior left atrial surface, also lateral to
the right pulmonary veins. When pathologic–clinical correla-
tions were investigated, Mehall and colleagues9 reported ac-
tive GP preferentially located in the upper right and left fat
pads along the pulmonary veins, with bilateral activity in
the majority of patients.9 As did Leonhardt,25 we found GP
clustered along the left pulmonary veins, although according
to Singh and coworkers,24 the highest number of GP can be
demonstrated on the fat pad of Waterston’s groove, either
on electrophysiologic stimulation or histologic analysis. Ac-
cordingly, our data agree with that of Mehall and colleagues,9
showing bilateral activity in the majority of patients, fol-
lowed by unilateral right-sided GP activity. Moreover, on
electrophysiologic study, we found active GPs to correlate
with a higher number of clustered GPs detectable at histol-
ogy. However, we did not found AF recurrences to correlate
with a specific histologic pattern.
In-hospital results were significantly better in patients un-
dergoing GP ablation because of the lower AF persistence at
aortic declamping or hospital discharge. Our results sug-
gested that GP function may affect the results of the AF ab-
lation in the postoperative course, confirming the findings416 The Journal of Thoracic and Cardiovascular Surgery c Auof Mehall and coworkers,9 who suggested that a persistent
activity of unisolated active GP may explain the 10% to
40% recurrence rate of AF after the Maze procedure alone.
Moreover, the impact of GP isolation in early postoperative
SR recovery can be attributed to the elimination of the vagal
reflexes and atrial susceptibility to AF, secondary to different
‘‘fibrillogenic’’ stimuli commonly encountered in the early
postoperative phase, such as electrolytic imbalance, systemic
inflammation, and hypovolemia.26
Fluid retention was one of the earliest recognized compli-
cations of the Maze procedure, related to biatrial appendec-
tomy, lower atrial natriuretic peptide secretion, increased
plasma arginine vasopressin and aldosterone levels, and tem-
porary lack of response of the atrial baroreceptors.27 Ad and
colleagues28 suggested that the abrupt cardioversion to SR
decreases postoperative atrial natriuretic peptide levels,
thus determining fluid retention. Despite the fact that biatrial
appendectomy was performed in both groups, we found
a lower need for furosemide at discharge and during fol-
low-up in patients undergoing GP isolation. It can be hypoth-
esized that the lower AF recurrences during hospitalization
and the reduced AF, AFL, AT recurrences during follow-
up after GP isolation, with a resulting better hemodynamic
status, may explain the lower need for furosemide in this
group. Accordingly, we found patients maintaining AF dur-
ing follow-up to require more furosemide than patients con-
verted to SR. Moreover, the reduced incidence of AF, AFL,
and AT with and without antiarrhythmic therapy may favor
the recovery of atrial function, thus resulting in a higher or
earlier recovery of E/A ratio (as found in group B) at echocar-
diographic follow-up. However, more studies exploring hor-
monal response and correlations between electrophysiology
and echocardiography are needed to substantiate such hy-
potheses.
Finally, it can be argued that a more aggressive approach
with atrial denervationmay favor the development of postoper-
ative junctional rhythm or impair the heart rate autonomic con-
trol and reflexes.7,22 When junctional rhythm was considered,
no differences were recorded in its prevalence in the 2 groups
either at aortic declamping or during hospitalization, so no dif-
ferences were recorded between the 2 groups in postoperative
need for definitive pacemaker implantation. When autonomic
imbalance was considered, it is well known from literature
studies7,22 that RF AF ablation modifies heart rate variability
and reduces baroreflex sensitivity in the early postoperative
course.22 However, we did not study heart rate variability;
therefore, further studies are welcome to clarify this topic.
When echocardiographic findings are considered, previ-
ous literature studies have demonstrated that restoration of
the SR is consistent with a reverse remodeling of the atrial di-
ameters, volumes, and function.29,30 However, if the entity of
such remodeling is due to the restoration of the rhythm or to
the restoration of the underlying valve disease, the evaluation
is still challenging. We confirmed our previous findings12gust 2008
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a significant reverse remodeling of atrial and ventricular di-
ameters only in case of SR restoration, which correlates
with a higher prevalence of E/A recovery at follow-up.
Therefore, patients with persistence of AF do not undergo
a reverse atrial remodeling or ventricular reverse remodeling,
despite the relief of the underlying valve pathology, which
may only ameliorate echocardiographic indexed left ventric-
ular mass. Therefore, ventricular remodeling is demonstrated
during follow-up only when SRmaintenance is guaranteed.12
These findings correlated with the evidence that despite
a comparable early postsurgical recovery of NYHA class in
the 2 treatment groups, patients demonstrating AF persis-
tence showed a lesser degree of symptomatic improvement
during follow-up.12 However, no differences can be detected
in atrial and ventricular remodeling between the 2 surgical
treatments, demonstrating that GP isolation did not further af-
fect reverse remodeling of the heart chambers. Finally, given
the comparable atrioventricular remodeling and the absence
of significant differences in follow-up freedom from AFL,
it is not surprising that patients undergoing GP isolation 1
mini-Maze have similar follow-up freedom from acute heart
decompensation and a comparable freedom from hospital re-
admission when compared with patients undergoing the left
1 right mini-Maze alone.
Extended GP isolation during AF ablation in mitral valve
surgery improves SR recovery during hospitalization and
adds a beneficial effect on follow-up freedom from AF and
the recovery of atrial function during echocardiographic
follow-up.
Study Limitations
The main limitation of the study is the limited number of pa-
tients enrolled in different periods; the lack of randomization
to treatment is another limitation. Moreover, the type and du-
ration of AFwere heterogeneous. All of these limitations stem
from the single-center design of the study, which, on the other
hand, guaranteed uniformity of the perioperativemanagement
of the patient population throughout the experimentation.
Certainly, further randomized studies or prolonged follow-
up would be required to confirm the beneficial role of GP
isolation during AF surgery.
The strengths of our study include its prospective design
and the sequential echocardiographic assessment of both
atrial and ventricular size and function before and after sur-
gery. Furthermore, there are few literature data with which
to compare the isolated Maze procedure with the Maze
procedure plus GP isolation.
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